Creo Medical Group PLC (LON:CREO – Get Free Report)’s stock price fell 0.8% during trading on Monday . The company traded as low as GBX 31.50 ($0.41) and last traded at GBX 31.75 ($0.41). 98,302 shares traded hands during trading, a decline of 85% from the average session volume of 643,425 shares. The stock had previously closed at GBX 32 ($0.41).
Creo Medical Group Trading Down 0.8 %
The firm has a market capitalization of £114.77 million, a PE ratio of -453.57 and a beta of 0.86. The stock’s 50-day moving average price is GBX 34.17 and its 200 day moving average price is GBX 36.11. The company has a debt-to-equity ratio of 13.88, a current ratio of 3.83 and a quick ratio of 2.19.
Creo Medical Group Company Profile
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
Recommended Stories
- Five stocks we like better than Creo Medical Group
- Investing in the High PE Growth Stocks
- Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
- Trading Halts Explained
- Has This Leading Tech Stock Halted the AI Surge?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Revolutionary Battery Stock Gains Momentum with 3D Silicon-Anodes
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
-WOLF.png?v=2024-07-28&h=45&w=95&zc=2){kind=small}